HOPE
Hope Bancorp, Inc.
HOPE's fundamentals are strong: revenue grew 26% and its operating margin rose 14 points to 28%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
HOPE Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
HOPE's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like HOPE.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
HOPE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.2x | $7.46 | -43% |
| Fair | 10x | $10.89 | -17% |
| Forward | 11x | $13.06 | — |
| Current | 13x | $13.06 | — |
| Expensive | 16x | $16.93 | +30% |
Historical ranges are pointers, not guarantees.
HOPE's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
HOPE Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for HOPE, but weaker profitability. However, they disagree widely on these estimates.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
HOPE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.18 | +14% |
| Q3 2026 | $1.04 | +167% |
| Q2 2026 | $1.00 | +186% |
| Q1 2026 | $0.52 | -33% |
| Q4 2025 | $0.46 | -44% |
| Q3 2025 | $0.39 | -54% |
| Q2 2025 | $0.35 | -61% |
| Q1 2025 | $0.78 | -22% |
| Q4 2024 | $0.82 | -27% |
HOPE has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
HOPE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $157.5M | +11% |
| Q2 2026 | $147.8M | +56% |
| Q1 2026 | $141M | +21% |
| Q4 2025 | $145.8M | +24% |
| Q3 2025 | $142M | +22% |
| Q2 2025 | $94.6M | -19% |
| Q1 2025 | $116.5M | -5.5% |
| Q4 2024 | $118M | -13% |
HOPE's revenue has grown year over year for five quarters in a row: $157M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +3.6 points |
| Q2 2026 | 29% | +60 points |
| Q1 2026 | 27% | +3 points |
| Q4 2025 | 27% | +1.1 points |
| Q3 2025 | 26% | -1.8 points |
| Q2 2025 | -32% | -61 points |
| Q1 2025 | 24% | -5.2 points |
| Q4 2024 | 26% | +0.9 points |
HOPE has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over HOPE on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
HOPE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $146.1M | +210% |
| Q2 2026 | $56M | +712% |
| Q1 2026 | $11.8M | -51% |
| Q4 2025 | $73.4M | +55% |
| Q3 2025 | $47.2M | -22% |
| Q2 2025 | $6.9M | +$35M |
| Q1 2025 | $24M | -13% |
| Q4 2024 | $47.4M | -38% |
HOPE has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
HOPE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +316K shares |
| 1 year | 0% | +30.8K shares |
| 3 years | +6.9% | +8.3M shares |
| 5 years | +4.7% | +5.7M shares |
| Available history | +1.4% | +1.7M shares |
HOPE has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2M |
| Q1 2026 | $6.7M |
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q4 2021 | $2.8M |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
HOPE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 1.1x | Healthy |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -2.0x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | 0.1x | Very low |
HOPE's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like HOPE.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
HOPE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.0 | Neutral |
| Stochastic | 12.2 | Oversold |
HOPE's weekly RSI is 47 (neutral) and its Stochastic is 12 (oversold).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
HOPE PE vs Financial Services Sector
| Metric | HOPE | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 3.5% below |
| PE % | 62 | 63 | 1 pt below |
HOPE is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
HOPE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.5 | 3% below |
| 20 week MA | $13.7 | 4.8% below |
| 50 week MA | $12.6 | 3.3% above |
| 100 week MA | $11.7 | 12% above |
| 200 week MA | $11.3 | 16% above |
HOPE has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
HOPE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.8 | $10.8 | -27% |
| 2021 | $10.8 | $14.5 | +35% |
| 2022 | $14.5 | $12.9 | -11% |
| 2023 | $12.9 | $12.1 | -6.4% |
| 2024 | $12.1 | $12.3 | +1.8% |
| 2025 | $12.3 | $11.3 | -8.5% |
| 2026 YTD | $11.3 | $13.1 | +16% |
HOPE has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.